Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Reactions02:06

Allergic Reactions

32.0K
Overview
32.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

1.7K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Fat of the Matter: IL6-Driven Lipid Rewiring in COPD.

American journal of respiratory cell and molecular biology·2026
Same author

Investigating the lasting effects of SARS-CoV-2 infection and the lung microbiome: no persistent microbial alterations in recovered COVID-19 patients with persistent radiological or respiratory abnormalities.

Access microbiology·2026
Same author

Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1-BH4-iNOS axis.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Investigating the impact of poly(beta amino) ester-mediated FOXJ1 mRNA delivery on differentiation of primary human bronchial epithelial cells.

Biology open·2026
Same author

Infection-induced glucose starvation triggers NINJ1-dependent macrophage lysis and Candida escape.

Nature communications·2026
Same author

IL4i1 activity generates oncometabolites that rescue neuroblastoma cells from oxidative death.

Cell reports·2026
Same journal

Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations.

Allergy·2026
Same journal

Dendritic Cell α-Ketoglutarate Regulates Tfh Polarization in Allergy.

Allergy·2026
Same journal

Decoding the "Metallic" Immune Imprint: Single-Cell Exposomics Reveals the Immune Imprint of Fire Smoke.

Allergy·2026
Same journal

Immunonutrition in Early Life: The Role of Complementary Feeding, Dietary Patterns, and Nutritional Exposures on the Health of Young Children-An EAACI Scoping Review.

Allergy·2026
Same journal

Detergent-Containing Toothpaste Decreases Esophageal Mucosal Impedance and Alters Salivary Properties in Humans.

Allergy·2026
Same journal

Global Variation in Timing of Allergenic Food Introduction for Food Allergy Prevention: An International Survey of Healthcare Professionals.

Allergy·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.2K

Protective Role for Itaconate During Inhaled Allergen Challenge.

Gesa J Albers1, Patricia P Ogger1, Christina Michalaki1

  • 1National Heart and Lung Institute, Imperial College London, London, UK.

Allergy
|October 25, 2025
PubMed
Summary
This summary is machine-generated.

Itaconate levels decrease after allergen exposure in mild asthma. While itaconate deficiency didn't affect asthma pathology in mice, inhaled itaconate reduced airway inflammation, suggesting a therapeutic potential for asthma.

Keywords:
airway inflammationallergen exposureasthmaitaconatemacrophage metabolism

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.3K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

23.3K

Related Experiment Videos

Last Updated: Jan 14, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.2K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.3K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

23.3K

Area of Science:

  • Immunology
  • Metabolomics
  • Respiratory Medicine

Background:

  • Asthma is a chronic respiratory disease involving airway inflammation and remodeling.
  • Macrophage function, crucial in asthma, is regulated by cellular metabolism, including the TCA cycle metabolite itaconic acid.
  • The role of itaconic acid during inhaled allergen challenge in asthma remains unclear.

Purpose of the Study:

  • To investigate the role of itaconate in the context of inhaled allergen challenge in asthma.
  • To determine how itaconate levels change following allergen exposure in mild allergic asthma patients and murine models.

Main Methods:

  • Measured sputum and bronchoalveolar lavage metabolite levels in human participants and wild-type/aconitase decarboxylase-deficient mice.
  • Assessed airway inflammation and lung function in mice.
  • Administered inhaled itaconate to house dust mite-exposed mice.

Main Results:

  • Sputum itaconate levels significantly decreased after allergen inhalation in mild asthmatics.
  • No significant differences in baseline sputum itaconate were observed between healthy controls and asthmatics of varying severity.
  • In mice, itaconate deficiency did not alter allergen-induced asthma pathology, but inhaled itaconate treatment reduced airway inflammation.

Conclusions:

  • Itaconate levels are dynamically altered following allergen challenge in mild asthmatics and murine models.
  • While itaconate deficiency itself did not exacerbate asthma pathology in mice, exogenous itaconate demonstrated anti-inflammatory effects.
  • Inhaled itaconate holds potential as a therapeutic agent for ameliorating inflammatory responses in allergic asthma.